Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's disease – current treatment
Ryan Wang, Ludy C. Shih
Current Opinion in Neurology (2023) Vol. 36, Iss. 4, pp. 302-308
Closed Access | Times Cited: 12

Showing 12 citing articles:

Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Giuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2993-2993
Open Access | Times Cited: 12
Global burden of Parkinson’s disease from 1990 to 2021: a population-based study
Mimi Li, Xiaofang Ye, Z. Jennifer Huang, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e095610-e095610
Open Access
Neuroprotective Mechanisms and Clinical Evidence for Acupuncture in Parkinson’s Disease: A Systematic Review
Li Jinting, Minmin Wu, Wenjing Song, et al.
Parkinson s Disease (2025) Vol. 2025, Iss. 1
Open Access
The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression in Parkinson's Disease: A Retrospective Study
Zhuoqun Wang, Jing Tian, Weixin Dai, et al.
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 5, pp. 607-615
Open Access | Times Cited: 2
[Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis
Jiawei Gui, Xiaoguang Sun, Shenglin Wen, et al.
PubMed (2024) Vol. 44, Iss. 2, pp. 270-279
Closed Access | Times Cited: 1
Shisandra Decoction Alleviates Parkinson’s Disease Symptoms in a Mouse Model Through PI3K/AKT/mTOR Signalling Pathway
Yawen Pan, Mojinzi Chen, Lulu Pan, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2011-2027
Open Access | Times Cited: 1
Early-morning OFF in Parkinson’s disease: A systematic literature review and current therapeutics
Hiroshi Kataoka, Kazuma Sugie
Clinical Neurology and Neurosurgery (2024) Vol. 245, pp. 108493-108493
Closed Access
Cellular senescence: A novel therapeutic target for central nervous system diseases
Shuang-Yin Lei, Yang Qu, Yu-Qian Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117311-117311
Open Access
Investigating Motor Complications and Thyroid Hormones, Sex Hormonal/Menstrual Links in Female Parkinson's Patients
Zhirong Wan, Fan Wang, Jing Zhao, et al.
Research Square (Research Square) (2024)
Closed Access
New Application of Ombuoside in Protecting Auditory Cells from Cisplatin-induced Ototoxicity via the Apoptosis Pathway
Xingxing Wu, Xixia Peng, Yue Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 20, pp. e39166-e39166
Closed Access
Circuit-specific gene therapy is knocking on the door of Parkinson’s disease
Yueqi Wang, Ming Yin, Zhe-Shan Guo
动物学研究 (2023) Vol. 44, Iss. 6, pp. 1152-1153
Open Access
Page 1

Scroll to top